Brand Description
LITFULO® (ritlecitinib) is the first and only FDA-approved treatment for severe alopecia areata in adults and adolescents aged 12 and older.
Associated Domains
IAB Categories:
Health & Fitness
IAB Ad Products:
Health and Medical ServicesPharmaceuticals
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|